Discreet_crop_web.jpg
DiabetesViCentra Closes Series C Funding to Expand Its Insulin Pump in EuropeViCentra Closes Series C Funding to Expand Its Insulin Pump in Europe
The proceeds from the $75 million funding will be used for the European launch of the company’s updated Kaleido insulin patch pump system.
Sign up for the QMED & MD+DI Daily newsletter.